Hikma Pharmaceuticals Logo

Hikma Pharmaceuticals

🇬🇧
HIK
GB00B0LCW083

Headquartered in the UK, Hikma Pharmaceuticals is a leading global pharmaceutical company. It develops, manufactures, and markets high-quality generic, branded, and injectable medicines. Through innovative healthcare solutions, Hikma is dedicated to improving patient care across the globe.

Next Quarterly Earnings

Thursday, February 25, 2027
Expected

Stock Price

Frequently asked questions

When did Hikma Pharmaceuticals last report quarterly earnings?

Hikma Pharmaceuticals last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 0.95 GBP.

How do I add the Hikma Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Beat
Estimate:£0.83
Actual:£0.95
Difference:+£0.12
Price reaction (1 day):+8.2 %
Q4 2025
Estimate:
Actual:£1.68
Price reaction (1 day):-16.9 %
Price reaction (7 days):-26.8 %

Company Information

Name
Hikma Pharmaceuticals
Ticker Symbol
HIK
ISIN
GB00B0LCW083
Country
🇬🇧
UK
Sector